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Influenza vaccination recommendations over time
Before 2000: Persons aged 65 or older
Persons with high-risk chronic medical conditions 
Pregnant women in the second or third trimester
Household contacts of the above
Health care workers
2000: Adults 50 and older
2004: Children aged 6—23 months
Household contact of children aged 0--23 months
Women who will be pregnant during influenza season
2006: Children aged 6—59 months
Household contacts of children aged 0—59 months
2008: All children aged 6 months—18 years
2010: All persons > 6 months in the US
During the last decade…
• More people getting vaccinated with influenza vaccines
• Greater use of vaccines in persons at high risk of 
complications
• More awareness of the need for vaccination
• Some skepticism of the value of influenza vaccination
Are influenza vaccines effective in preventing influenza-
associated illnesses each year?
Measuring influenza vaccine effectiveness in the U.S.
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During the last decade…
• More people getting vaccinated with influenza vaccines
• Greater use of vaccines in persons at high risk of 
complications
• More awareness of the need for vaccination
• Some skepticism of the value of influenza vaccination
Are influenza vaccines effective in preventing influenza-
associated illnesses each year?
Yes.
… but the effectiveness varies by season, 
population, and outcome measured
Communicating influenza VE
Impact of influenza vaccination program
• Question: 
Are influenza vaccine programs effective in reducing 
influenza-associated health outcomes in the 
population?
• Goal:  
Estimate the number of averted influenza-associated 
outcomes that result from influenza vaccination in the 
United States
Impact of influenza vaccination program
• Advantages:
 Consistent and systematic approach across seasons
 Uses data collected as core program activities (Influenza 
Division and Immunization Services Division)
 Estimates can be updated annually
 Illness/outcomes averted may be easier and more 
meaningful way to communicate value of  vaccine
Impact of influenza vaccination program
1. Estimate observed annual burden of influenza-associated 
outcomes
2. Estimate observed risk of influenza-associated outcomes 
among susceptible individuals
 Using data on annual vaccine coverage and vaccine effectiveness
3. Calculate expected burden of influenza-associated 
outcomes in population with no vaccination
4. Calculate difference in outcomes attributable to vaccination 
program
Kostova D, et al. 2013. PLoS One. 8(6): e66312.
Burden of Disease
• Since 2010-11, influenza has led annually to:
 19 – 35 million cases of influenza respiratory disease
 3.4 – 15.2 million clinic visits
 110,000 – 592,000 hospitalizations
 5,300 – 39,000 deaths
Reed C, et al. 2015. PLoS One. 10(3): e0118369.
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http://www.cdc.gov/flu/fluvaxview/reports/reporti1314/trends/index.htm
Vaccine Effectiveness
• Varies by age group and season, 2010 – 2014*:
 6 mos – 4 yrs:   47 – 68%
 5 – 19 yrs:   46 – 61%
 20 – 64 yrs:   50 – 52%
 65+ yrs:   32 – 39%
*US Flu VE network, annual estimates
Disease Averted by Vaccination
• Since 2010-11, influenza vaccination has averted annually:
 1.6 – 7.2 million cases of influenza respiratory disease
 750,000 – 3.2 million clinic visits
 30,000 – 120,000 hospitalizations
 2,200 – 16,000 deaths
Communicating influenza vaccine impact
MMWR Morb Mortal Wkly Rep 2013;62:997–1000
MMWR Morb Mortal Wkly Rep 2014; 63:1189–94
Morbidlty and Mortality Weekly Report 
Estimated Influenza Illnesses and Hospitalizations Averted by Influenza 
Vaccination - United States, 2012-13 Influenza Season 
Morbidity and Mortality Weekly Report 
Estimated Influenza Illnesses and Hospitalizations 
Averted by Vaccination - United States, 2013-14 Influenza Season 
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the benefits of flu vaccination 
1.2 mil ion 3.1 mil ion 90,000 
enough people to form 
a line from Maine to Oregon 
more than the population 
of the crty of Chicago 
enough to fill Madison Square 
Garden more than 4 times 
DATA: Morbktty and Mc11Btty Weekly Report [MMW'I~ Oeoelrtler 12, 2014: VOi. 63, No. 49 NCUill!g,-411 112.1:Ul014 
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Conclusion
• Substantial annual averted disease burden from the 
influenza vaccination program
 Varies by VE and annual disease burden
• Program improvements will be made by 
 increasing coverage in non-elderly persons
 improving effectiveness of vaccines, especially in elderly 
persons
Conclusion
• Annual estimates provide
 Comparison across seasons to examine impact of changes 
in burden, VE, and VC
 Help identifying and prioritizing data needed to routinely 
evaluate program impact 
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